What is TG Therapeutics's net debt / EBITDA?

TG Therapeutics (TGTX) reported net debt / EBITDA of 2× in Q2 2026.

How has TG Therapeutics's net debt / EBITDA changed year-over-year?

TG Therapeutics's net debt / EBITDA increased by 37.4% year-over-year, from 1.5× to 2×.

What does net debt / EBITDA mean?

Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.

TG Therapeutics (TGTX) Net debt / EBITDA

Screener

Net debt / EBITDA at other companies

BiogenBIIB

2.9×+1.5×

Mirum Pharmaceuticals, Inc.MIRM

-116.1×—

Neurocrine BiosciencesNBIX

0.2×-0.3×

Rigel PharmaceuticalsRIGL

0.3×+0.2×

Zevra Therapeutics, Inc.ZVRA

-1.6×—

AbbVieABBV

2.5×—

Other financials

Income statement

See full

Revenue$240.3M+70.3%

Gross profit$199.1M+62.9%

Operating income$21.7M-37.8%

Net income$7.8M-72.4%

EPS (diluted)$0.05-70.6%

Balance sheet

See full

Cash & equivalents$482.6M+274%

Total debt$754.4M+197%

Total equity$604.1M+119%

Total assets$1.6B+133%

Cash flow

See full

Operating cash flow$39.3M—

CapEx$293.0K+598%

Free cash flow$39.0M—

Valuation

See full

Market cap$7.64B+73.6%

Enterprise value$7.91B+74.9%

P/E17.3×-55.5×

P/S9.6×-0.1×

Profitability

See full

Gross margin82.4%-4.6pp

Operating margin17.1%-1.9pp

Net margin55.2%+41.9pp

FCF margin-6,328.4%+4,773pp

Returns & leverage

See full

Return on equity100.3%+73.6pp

Debt / equity1.2×+0.3×

Current ratio4.3×+0.4×

Where this comes from

Calculated from TG Therapeutics’s reported figures.

net debt/ebitda=2×

Based on the most recent quarter.

The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →

Filed: Aug 5, 2026, 5:01 PM EDT
Fiscal quarter: Q2 FY2026
Calendar quarter: Q2 2026
Accession: 0001437749-26-025955

FAQ

What is TG Therapeutics's net debt / EBITDA?: TG Therapeutics (TGTX) reported net debt / EBITDA of 2× in Q2 2026.
How has TG Therapeutics's net debt / EBITDA changed year-over-year?: TG Therapeutics's net debt / EBITDA increased by 37.4% year-over-year, from 1.5× to 2×.
What does net debt / EBITDA mean?: Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.

Ask your AI about TG Therapeutics's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

TG Therapeutics TGTX Net debt / EBITDA

Net debt / EBITDA at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about TG Therapeutics's net debt / ebitda.